摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-<(carbomethoxy)methyl>-5-methylfuran | 60670-00-0

中文名称
——
中文别名
——
英文名称
2-<(carbomethoxy)methyl>-5-methylfuran
英文别名
methyl ester of 5-methyl-2-furylacetic acid;methyl 2-(5-methylfur-2-yl)acetate;methyl 5-methyl-2-furylacetate;2-Furanacetic acid, 5-methyl-, methyl ester;methyl 2-(5-methylfuran-2-yl)acetate
2-<(carbomethoxy)methyl>-5-methylfuran化学式
CAS
60670-00-0
化学式
C8H10O3
mdl
——
分子量
154.166
InChiKey
LTOMLWLBUMAZCH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    94 °C
  • 沸点:
    190.6±25.0 °C(Predicted)
  • 密度:
    1.090±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    39.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity
    摘要:
    A series of gamma-lactam prostaglandin E(1) analogs bearing a 16-phenyl moiety in the omega-chain and aryl moiety in the alpha-chain were synthesized and biologically evaluated. Among the tested compounds, gamma-lactam PGE analog 3 designed as a structural hybrid of 1 and 2 was discovered as the most optimized EP2/EP4 dual agonist with excellent subtype-selectivity (K(i) values: mEP2 = 9.3 nM, mEP4 = 0.41 nM). A structure-activity relationship study is presented. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.10.109
  • 作为产物:
    描述:
    [5-Phenylselanylmethyl-dihydro-furan-(2Z)-ylidene]-acetic acid methyl ester 在 Amberlist 、 双氧水碳酸氢钠 作用下, 以 甲醇 为溶剂, 反应 24.0h, 生成 2-<(carbomethoxy)methyl>-5-methylfuran
    参考文献:
    名称:
    Elimination reactions of terminal .beta.-oxy selenoxides. Synthesis of aryl and vinyl enol ethers and of furans, oxazoles, and thiazoles
    摘要:
    Elimination reactions of terminal selenoxides holding an alkoxy group in the beta position, RCH-(OR)CH2SeOPh, are usually difficult and can give rise to complex reaction mixtures. We report that these reactions take place more easily whenever the oxygen atom is linked to an unsaturated group (-CH=CHR, -Ar, -CR=O, -CH=NR). These selenoxides are easily available, and the elimination reaction was employed to effect useful syntheses of both open-chain and cyclic aryl and vinyl enol ethers. Moreover, by simple isomerization with acids or bases the cyclic derivatives can be transformed into the corresponding furans. The same procedure has been employed to synthesize substituted oxazoles and thiazoles also.
    DOI:
    10.1021/jo00058a011
点击查看最新优质反应信息

文献信息

  • Unified Approach to Furan Natural Products via Phosphine‐Palladium Catalysis
    作者:Violet Yijang Chen、Ohyun Kwon
    DOI:10.1002/anie.202015232
    日期:2021.4.12
    the construction of tetraalkyl furans remains non‐trivial. The prevalence of alkyl groups in bioactive furan natural products, combined with the desirable bioactivities of tetraalkyl furans, calls for a general synthetic protocol for polyalkyl furans. This paper describes a Michael–Heck approach, using sequential phosphine‐palladium catalysis, for the preparation of various polyalkyl furans from readily
    多烷基呋喃在自然界中广泛存在,通常发挥重要的生物学作用。尽管合成四取代呋喃的方法有很多,但四烷基呋喃的构建仍然很重要。生物活性呋喃天然产物中烷基的普遍存在,加上四烷基呋喃所需的生物活性,需要一种多烷基呋喃的通用合成方案。本文描述了一种 Michael-Heck 方法,使用顺序膦-催化,从容易获得的前体制备各种聚烷基呋喃。该方法的多功能性通过属于不同类别的九种不同的多烷基化呋喃天然产物(即呋喃萜玫瑰呋喃、倍半糖呋喃和米卡尼呋喃)的全合成来说明;海洋天然产物plakorsin A、B、D和plakorsin D甲酯;以及呋喃脂肪酸3D5和氢木霉素。
  • 一种呋喃乙酸酯类化合物的合成方法
    申请人:中国科学院兰州化学物理研究所
    公开号:CN112898247B
    公开(公告)日:2023-03-14
    本发明公开了一种呋喃酸酯类化合物的合成方法,是以糠醇类化合物为原料,一氧化碳气体为羰源,酯类化合物为添加剂,在有机溶剂中、催化剂的作用下进行羰化反应,得到呋喃酸酯类化合物。其中催化剂为碱、属盐、含膦配体的组合体。本发明利用糠醇类化合物为原料,通过羰化实现糠醇类化合物的碳数的增长合成了呋喃酸酯类化合物,其合成工艺简单,合成条件温和,成本低,呋喃乙酸酯类的收率高,同时实现了可再生资源生物糠醇的转化利用。
  • Thiophene derivatives and process for preparation thereof
    申请人:Sagami Chemical Research Center
    公开号:US04051151A1
    公开(公告)日:1977-09-27
    Commercially advantageous processes for preparing thienylacetic acid, furylacetic acid or alkyl esters of these. Novel thiophene or furan derivatives that can be used as starting materials for preparing the above compounds. Processes for preparing these starting materials are also provided.
    用于制备噻吩乙酸呋喃乙酸或它们的烷基酯的商业优势工艺。可以用作制备上述化合物的起始材料的新型噻吩呋喃生物。还提供了制备这些起始材料的工艺。
  • Agent for inhibition of cytokine production and agent for inhibition of cell adhesion
    申请人:Chihiro Masatoshi
    公开号:US20070238758A1
    公开(公告)日:2007-10-11
    The present invention provides an agent for inhibiting cytokine production or cell adhesion, comprising at least one compound selected from the group consisting of thiazole derivatives represented by the following general formula: [wherein R 1 is a phenyl group which may have a lower alkoxy group(s) as a substituent(s) on the phenyl ring, and R 2 is a group represented by the following general formula: (wherein R 3 's, which may be the same or different, are each a carboxyl group, a lower alkoxy group or the like) or the like] and salts thereof.
    本发明提供了一种抑制细胞因子产生或细胞黏附的药剂,包括至少一种选择自以下通式所示的噻唑生物组中的化合物: [其中R1是苯基,苯基上可能有一个或多个较低的烷氧基作为取代基,R2是以下通式所示的基团之一: (其中R3'可能相同或不同,分别是羧基、较低的烷氧基或类似物)或其盐。]
  • NOVEL ADENINE COMPOUND AND USE THEREOF
    申请人:ISOBE Yoshiaki
    公开号:US20120178743A1
    公开(公告)日:2012-07-12
    An antiallergic agent for topical administration containing an adenine compound of general formula (1): [wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X 1 represents oxygen, sulfur, NR 1 (R 1 represents hydrogen or alkyl), or a single bond; Y 1 represents a single bond, alkylene, etc.; Y 2 represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q 1 and Q 2 represents —COOR 10 (wherein R 10 represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.
    一种用于局部给药的抗过敏剂,包含一种通式(1)的腺嘌呤化合物:[其中环A代表一个6到10个成员的单环或双环芳香烃或一个5到10个成员的单环或双环芳香杂环,其中包含1到3个杂原子,选择自0到2个氮原子,0或1个氧原子和0或1个原子;n是0到2的整数;m是0到2的整数;R代表卤素,(未)取代的烷基等;X1代表氧,,NR1(R1代表氢或烷基)或单键;Y1代表单键,亚烷基等;Y2代表单键,亚烷基等;Z代表亚烷基;且Q1和Q2中的至少一个代表—COOR10(其中R10代表(未)取代的烷基等),等的药学上可接受的盐。
查看更多